Reply

Affiliations

¹ Department of Clinical Medicine, "Sapienza" University of Rome, Rome, Italy.
² Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Rome, Italy.

Comment

Silvia Nardelli et al. Hepatology. 2019 Aug.

. 2019 Aug;70(2):762-763.

doi: 10.1002/hep.30639.

¹ Department of Clinical Medicine, "Sapienza" University of Rome, Rome, Italy.
² Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Rome, Italy.

No abstract available

Comment on

Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.
Nardelli S, Gioia S, Ridola L, Farcomeni A, Merli M, Riggio O. Nardelli S, et al. Hepatology. 2019 Aug;70(2):640-649. doi: 10.1002/hep.30304. Epub 2019 Mar 4. Hepatology. 2019. PMID: 30289992
Letter to the Editor: Proton Pump Inhibitors in Cirrhosis: A Marker of Morbid Conditions or a Cause of Mortality?
Moon AM, Hayashi PH, Barritt AS 4th. Moon AM, et al. Hepatology. 2019 Aug;70(2):761-762. doi: 10.1002/hep.30642. Hepatology. 2019. PMID: 30951188 Free PMC article. No abstract available.
Letter to the Editor: Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.
Chen YJ, Tsai CF, Wang YP, Lu CL. Chen YJ, et al. Hepatology. 2019 Aug;70(2):760-761. doi: 10.1002/hep.30641. Hepatology. 2019. PMID: 30959562 No abstract available.